Approval · Notice of Compliance 37709 · 2026
EXDENSUR: Notice of Compliance 37709
Issued June 15, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37709
- Date
- June 15, 2026
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- DEPEMOKIMAB 100 MG per ML